IP Verse

Bifunctional Polypeptides - EP3112376

The patent EP3112376 was granted to Immunocore on Jan 23, 2019. The application was originally filed on May 19, 2010 under application number EP16176246A. The patent is currently recorded with a legal status of "Revoked".

EP3112376

IMMUNOCORE
Application Number
EP16176246A
Filing Date
May 19, 2010
Status
Revoked
Jun 4, 2021
Grant Date
Jan 23, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

STORZApr 29, 2019- -

Patent Citations (17) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONWO03020763
OPPOSITIONEP3112376
OPPOSITIONUS2004253632
OPPOSITIONUS2009042285
OPPOSITIONWO0193913
OPPOSITIONWO03020763
OPPOSITIONWO2004074322
OPPOSITIONWO2006037960
OPPOSITIONWO2008135734
OPPOSITIONWO2010133828
SEARCHUS2004253632
SEARCHWO0193913
SEARCHWO03020763
SEARCHWO2004074322
SEARCHWO2005113595
SEARCHWO2006037960
SEARCHWO9960120

Non-Patent Literature (NPL) Citations (28) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- BELMONT HJ. ET AL., CLIN IMMUNOL, (2006), vol. 121, no. 1, pages 29 - 39-
DESCRIPTION- CHAMES P. ET AL., PROC NATL ACAD SCI USA, (2000), vol. 97, no. 14, pages 7969 - 74-
DESCRIPTION- DENKBERG G. ET AL., J IMMUNOL, (2003), vol. 171, no. 5, pages 2197 - 207-
DESCRIPTION- MARGET M. ET AL., MOL IMMUNOL, (2005), vol. 42, no. 5, pages 643 - 9-
DESCRIPTION- MOSQUERA LA. ET AL., J IMMUNOL, (2005), vol. 174, no. 7, pages 4381 - 8-
DESCRIPTION- NEETHLING FA. ET AL., VACCINE, (2008), vol. 26, no. 25, pages 3092 - 102-
DESCRIPTION- PAN, BIOTECHNIQUES, (2000), vol. 29, no. 6, pages 1234 - 8-
DESCRIPTION- PAN ET AL., BIOTECHNIQUES, (2000), vol. 29, no. 6, pages 1234 - 8-
DESCRIPTION- WEN J. ET AL., CANCER IMMUNOL IMMUNOTHER, (2008), vol. 57, no. 12, pages 1781 - 94-
DESCRIPTION- WILLEMSEN RA. ET AL., J IMMUNOL, (2005), vol. 174, no. 12, pages 7853 - 8-
DESCRIPTION- WILLEMSEN R. ET AL., CYTOMETRY A, (2008), vol. 73, no. 11, pages 1093 - 9-
OPPOSITION- DAVIS CB et al., "Immunocytokines: am- plification of anti-cancer immunity", Cancer Immunol Immunother, (20030000), vol. 52, pages 297 - 308, XP002350474-
OPPOSITION- PENG LS et al., "A single- chain IL -12 IgG3 antibody fusion protein re- tains antibody specificity and IL -12 bioactiv- ity and demonstrates antitumor activity", J Immunol., (19990701), vol. 163, no. 1, pages 250 - 258, XP002967832-
OPPOSITION- WEN J et al., "Targeting activity of a TCR/ IL -2 fusion protein against established tumors", Cancer Immunol Immunother, (20081200), vol. 57, no. 12, pages 1781 - 1794, XP019654552
OPPOSITION- ARGOS P, "An investigation of oligopeptides linking domains in protein tertiary structures and possible candidates for general gene fu- sion", J Mol Biol., (19900220), vol. 211, no. 4, pages 943 - 958, XP009043079
OPPOSITION- DENKBERG G et al., "Recombinant anti- bodies with T- cell receptor-like specificity: novel tools to study MHC class I presenta- tion", Autoimmun Rev., (20060400), vol. 5, no. 4, pages 252 - 7, XP005428923
OPPOSITION- SADELAIN M et al., "The promise and potential pitfalls of chimeric antigen receptors", HHS Public Access Author Manuscript, (20090401), vol. 21, no. 2, pages 1 - 18, XP055589937
OPPOSITION- PULE M et al., "ARTIFICIAL T- CELL Cited during examination RECEPTORS", CYTOTHERAPY, (20030101), vol. 5, no. 3, pages 211 - 226, XP008028247
OPPOSITION- XIONG et al., "Development of tumor targeting anti-MUC-1 multimer: effects of di-scFv unpaired cyste- ine location on PEGylation and tumor bind- ing", Protein Engineering, Design and Selection, (20060801), vol. 19, no. 8, pages 359 - 367, XP002714202
OPPOSITION- KLECHEVSKY et al., "Antitumor activity of im- munotoxins with T- cell receptor-like specific- ity against human melanoma xenografts", Cancer Res., (20080801), vol. 68, no. 15, pages 6360 - 6367, XP002597798
OPPOSITION- RUF AND LINDHOFER, "Induction of a long-lasting antitumor immunity by a trifunctional bispecific antibody", Blood., (20011015), vol. 98, no. 8, pages 2526 - 2534, XP002660756
OPPOSITION- ORTIZ-SANCHEZ E et al., "Antibody-cytokine fusion pro- teins: applications in cancer therapy", HHS Public Access Author Manuscript, (20080000), vol. 8, no. 5, pages 1 - 42, XP055535112
SEARCH- SCHLITT H J ET AL, "DIFFERENT ACTIVATION STATES OF HUMAN LYMPHOCYTES AFTER ANTIBODY-MEDIATED STIMULATION VIA CD3 AND THE ALPHA-BETA T CELL RECEPTOR", SCANDINAVIAN JOURNAL OF IMMUNOLOGY, (1990), vol. 32, no. 6, ISSN 0300-9475, pages 717 - 726, XP002600946 [A] 1-8,10-12 * abstract *-
SEARCH- GRAZYNA LIPOWSKA-BHALLA ET AL, "Targeted immunotherapy of cancer with CAR T cells: achievements and challenges", CANCER IMMUNOLOGY, IMMUNOTHERAPY, SPRINGER, BERLIN, DE, (20120422), vol. 61, no. 7, doi:10.1007/S00262-012-1254-0, ISSN 1432-0851, pages 953 - 962, XP035074376 [XP] 1-8,10-12 * the whole document *
SEARCH- SADELAIN M ET AL, "The promise and potential pitfalls of chimeric antigen receptors", CURRENT OPINION IN IMMUNOLOGY, ELSEVIER, OXFORD, GB, vol. 21, no. 2, doi:10.1016/J.COI.2009.02.009, ISSN 0952-7915, (20090401), pages 215 - 223, (20090325), XP026058399 [X] 1-8,10-12 * the whole document *
SEARCH- PULE M ET AL, "ARTIFICIAL T-CELL RECEPTORS", CYTOTHERAPY, ISIS MEDICAL MEDIA, OXFORD, GB, (20030101), vol. 5, no. 3, doi:10.1080/14653240310001488, ISSN 1465-3249, pages 211 - 226, XP008028247 [X] 1-8,10-12 * the whole document *
SEARCH- LI BOHUA ET AL, "Construction and characterization of a humanized anti-human CD3 monoclonal antibody 12F6 with effective immunoregulation functions", IMMUNOLOGY, (200512), vol. 116, no. 4, ISSN 0019-2805, pages 487 - 498, XP002600947 [A] 1-8,10-12 * abstract *
SEARCH- BIBOLLET-RUCHE FREDERIC ET AL, "The Quality of Chimpanzee T-Cell Activation and Simian Immunodeficiency Virus/Human Immunodeficiency Virus Susceptibility Achieved via Antibody-Mediated T-Cell Receptor/CD3 Stimulation Is a Function of the Anti-CD3 Antibody Isotype", JOURNAL OF VIROLOGY, (200810), vol. 82, no. 20, ISSN 0022-538X, pages 10271 - 10278, XP002600945 [A] 1-8,10-12 * abstract * * page 10272, column 1, paragraph 4 *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents